![]() |
市场调查报告书
商品编码
1372034
到 2030 年免疫保健补充剂市场预测:按产品类型、来源、型态、配销通路、客户意愿、型态、用途和地区进行的全球分析Immune Health Supplements Market Forecasts to 2030 - Global Analysis By Product Type, Source, Form, Distribution Channel, Customer Orientation, Mode of Medication, Application and By Geography |
根据 Stratistics MRC 的数据,2023 年全球免疫保健补充剂市场规模为 711 亿美元,预计预测期内年复合成长率为 13.4%,到 2030 年将达到 1,714 亿美元。
免疫补充食品是食品支持和增强人体免疫系统的营养补充,这些补充剂通常含有被认为可以增强对病原体和外部威胁的免疫反应的维生素和矿物质、抗氧化剂和天然化合物。常见成分包括维生素 C、维生素 D、锌、紫锥菊和益生菌,可降低疾病风险并帮助从感染疾病和疾病中恢復。
根据《营养商业杂誌》报道,2020 年 4 月免疫补充剂的购买量大幅增加也就不足为奇了。
由于健康意识的提高、生活方式的改变和体重管理计划的增加等要素,预计该市场将会扩大。例如,人们从每天消费的食品和饮料中寻求额外的好处和安全。此外,营养补充食品确保满足您所有营养需求的有用且实用的方法。因此,在预测期内,对免疫保健补充剂的需求可能会增加。
这项技术由感测器、设备和软体结构,需要大量的初期成本来获取和部署。此外,持续的维护、培训和系统更新也会增加总拥有成本。对于预算有限的医疗保健机构和其他机构来说,这种成本可能会成为障碍并阻碍普及。儘管减少医疗保健相关感染和提高病患安全具有长期好处,但一些公司可能会发现初期成本成为采用手部卫生监测系统的障碍。因此,这些要素正在阻碍市场的成长。
顾客逐渐收集被认为能够增强身体防御力和免疫力的有效产品。此外,免疫保健品製造商正在确定哪些物质具有临床上确定的益处,因为消费者高度重视自己的健康。此外,製造商对製作保健品的基本补充食品需求量很大,例如益生菌、omega-3 脂肪酸、接骨木果和蘑菇。此外,免疫保健补充食品的研发也不断扩大,食品提供真正有效的增强免疫力的营养补充。因此,这些要素是市场扩张的主要驱动力。
当药物与其他药物混合或在手术前服用时,免疫系统会发生变化。对于患有某些医学问题的人来说,增强免疫力的补充剂也可能会产生问题。此外,许多补充剂的效果尚未在儿童或孕妇中进行研究,这些补充剂被视为食品而不是食品。此外,补充剂的品质和对身体的影响尚未经过食品药物管理局的评估。营养补充的包装盒上也没有列出潜在的副作用列表,也没有关于所选锭剂尺寸指南的法规。老年人面临的风险更大,市场规模不断缩小。
免疫保健补充食品市场受到了 COVID-19大流行的不利影响。然而,由于製造限制、供应链中断和法规不确定性,市场遇到了困难。封锁、旅游限制和经济不确定性影响了消费者购买力和个人支出,导致销售下降。此外,人们的兴趣已从免疫补充剂转向疫苗接种和 COVID-19 药物治疗。因此,这些因素综合起来,导致疫情期间免疫保健食品的市场扩张放缓。
由于使用营养补充食品来改善整体健康和增强免疫功能,维生素和矿物质补充剂领域预计将占据最大份额。此外,虽然与手部卫生监测技术无关,但本节强调了感染控制综合策略的价值。此外,透过保持足够量的重要维生素和矿物质,医疗保健专业人员和个人可以增强身体对感染的天然防御能力,透过营养供给促进身体健康并减少感染的脆弱性。这支持手部卫生监测工作,突显感染的复杂性预防和健康维护。
由于肥皂和消毒剂等手部卫生产品中使用植物来源物质,预计植物基细分市场在预测期内将呈现最高的年复合成长率。此外,这种市场区隔錶明,客户对錶达永续性和天然成分理想的产品越来越偏好,并且与环保实践的更广泛趋势相一致,增加了提供相容的植物来源部卫生产品的价值。因此,这些方面都在逐步加大市场规模。
由于人口成长和购买力上升,亚太地区在估计期间占据了最大的市场占有率,最终促进了保健补充食品市场的扩张。此外,亚太地区既是银杏叶等原料的来源地,也是新产品线的灵感来源,包括基于印度阿育吠陀和传统医学的草药滋补品和饮料。此外,自我药疗在该地区比西方竞争更为普及,这对非处方药产业产生了显着的正面影响。对阿育吠陀等传统产品的需求正在吸引国际和本地投资者来到亚太地区,将出口集中到需求中心。因此,这些方面最终推动了市场的扩张。
预计北美在预测期内将实现盈利成长。例如,根据美国疾病管制与预防中心 (CDC) 的数据,约有 3,420 万美国患有糖尿病,而美国8,800 万成年人(约占美国的三分之一)患有糖尿病前期。因此,随着人们健康意识的增强,预计北美将继续主导免疫保健品市场。
According to Stratistics MRC, the Global Immune Health Supplements Market is accounted for $71.1 billion in 2023 and is expected to reach $171.4 billion by 2030 growing at a CAGR of 13.4% during the forecast period. Immune health supplements are dietary products formulated to support and strengthen the body's immune system, these supplements typically contain a combination of vitamins, minerals, antioxidants, and natural compounds that are believed to enhance the immune response to pathogens and external threats. Common ingredients include vitamin C, vitamin D, zinc, echinacea, and probiotics, which help in reduce the risk of illness, and aid in recovery from infections or diseases.
According to the Nutrition Business Journal, not surprisingly, the purchase of immune supplements in April 2020 surged significantly.
The market is projected to rise as a result of factors such as rising health awareness, changing lifestyles, and an increase in weight management programs. For instance, people seek out additional advantages or safety from the foods and drinks they consume every day. Furthermore, dietary supplements are a helpful and practical way to guarantee that all nutritional demands are met. It follows that during the forecast period, demand for immune health supplements is likely to increase.
The technology, which comprises sensors, equipment, and software, can require a substantial initial expenditure in order to acquire and implement. Moreover, the total cost of ownership is also increased by continuing upkeep, training, and system updates. Healthcare facilities and other institutions with limited budgets may find this expense to be an obstacle, which would prevent widespread adoption. Some businesses may view the initial cost as an obstacle to adopting Hand Hygiene Monitoring Systems, despite the long-term advantages in terms of decreased healthcare-associated infections and increased patient safety. Therefore, these factors hampers the growth of the market.
Customers are progressively collecting effective products that they think can boost defence and immunity in the body. Additionally, immunity health supplement makers are deciding on substances that would have clinically established advantages because consumers place a high priority on health. Moreover, manufacturers have a significant demand for essential ingredients needed to make health supplements like probiotics, omega-3 fatty acids, elderberry, and button mushrooms. Furthermore, research and development efforts on immune health supplements are expanding consistently to provide really efficient dietary supplements for immunity-boosting purposes. Therefore, these factors significantly drive the market expansion.
Immune system will have changes when mixed with other medications or taken before surgery, several supplements which may cause negative side effects. For people with specific medical issues, immunity-boosting supplements can also be problematic. Additionally, many supplements' effects haven't been studied in children, pregnant women, or other groups, these supplements are controlled as foods rather than medications. Furthermore, the quality of supplements and their effects on the body are not evaluated by the Food and Drug Administration. There are no regulations on the list of potential side effects on the box of dietary supplements or guidelines for the chosen tablet size. Thus, as a result, the older population is being put at great risk, thereby hampering the market size.
On the market for immune health supplements, the COVID-19 pandemic has had a detrimental effect. However, as a result of manufacturing limitations, supply chain disruptions, and regulatory uncertainty, the market encountered difficulties. Lockdowns, travel restrictions, and economic uncertainty all had an effect on consumer purchasing power and personal expenditure, which resulted in a drop in sales. Moreover, in addition, attention was diverted from immune health supplements in favor of vaccinations and pharmacological therapies for COVID-19. Therefore, these elements combined to cause a slowdown in the market's expansion for immune health supplements during the epidemic.
The vitamins & minerals supplements segment is estimated to hold the largest share, due to the use of dietary supplements to improve general wellness and boost immune function. Additionally, even though it has nothing to do with hand hygiene monitoring technology, this section emphasizes the value of an all-encompassing strategy for infection management. Moreover, the body's natural defences against infections can be strengthened by ensuring healthcare workers and individuals maintain proper quantities of vital vitamins and minerals, it emphasizes the complex nature of infection prevention and health maintenance by encouraging good health through nutritional supplementation and minimizing vulnerability to infections, which supports hand hygiene monitoring activities.
The plant based segment is anticipated to have highest CAGR during the forecast period, due to the use of substances derived from plants in hand hygiene products like soaps and sanitizers, an eco-aware approach to hand hygiene is provided by these sustainable, cruelty-free, and environmentally friendly solutions. Moreover, this market segment shows a growing customer preference for goods that represent their ideals of sustainability and all-natural components, in line with a broader trend toward environmentally friendly practices, it emphasizes the value of providing plant-based hand hygiene products to cater to eco-conscious individuals and businesses. Therefore, these aspects gradually propel the market size.
Asia Pacific commanded the largest market share during the extrapolated period owing to the population growth and rising purchasing power have ultimately aided in the expansion of the health supplement market. Additionally, the Asia-Pacific area serves as a source of raw materials like ginkgo biloba as well as an inspiration for new product lines, including herbal tonics and beverages based on Indian Ayurveda and traditional Chinese medicine. Moreover, self-medication is becoming more popular in the region compared to western competitors, which has had a huge positive impact on the OTC industry. The demand for conventional goods like Ayurveda has drawn international and local investors to the Asia-Pacific area, where they are concentrating on exports to demand centers. Therefore, these aspects consequently drive the market expansion.
North America is expected to witness profitable growth over the projection period, owing to the people's rising awareness of these topics, it is anticipated that health and well-being will continue to be at the forefront in the near future. For instance, almost 34.2 million Americans have diabetes, according to the Centers for Disease Control and Prevention (CDC), and in the United States, 88 million adults, or about one-third of the population, have prediabetes, in addition, regional development would be sparked by the rising prevalence of lifestyle diseases like diabetes and obesity. Therefore, as people's awareness of their own wellbeing and health grows, it is projected that North America will continue to dominate the market for immune health supplements.
Some of the key players in the Immune Health Supplements Market include: Abbott Laboratories, American Health, Amway Corp, Bayer AG, Boehringer Ingelheim, Danone, GlaxoSmithKline Inc., Herbalife Nutrition of America, Inc., Himalaya Global Holdings Ltd., Nestle, Novartis, Pfizer Inc., Sanofi, Sun Pharmaceutical Industries Limited, Swisse Wellness Pty Ltd., The Nature's Bounty Co. and Unilever.
In September 2023, Nestle announced an agreement with Advent International to acquire a majority stake in Grupo CRM, a premium chocolate player in Brazil. Grupo CRM operates a successful direct-to-consumer model, with more than 1 000 chocolate boutiques under the Kopenhagen and Brasil Cacau brands and a strong, growing online presence.
In March 2023, Nestle and UNESCO announced a new partnership to provide young people with the resources and the skills they need to develop and carry forward innovative solutions to achieve positive social impact in their communities.
In July 2023, DTx Pharma, a preclinical stage biotechnology company addressing the delivery challenges of oligonucleotide therapeutics with its Fatty Acid Ligand Conjugated OligoNucleotide (FALCON™) platform, announced that it has been acquired by Novartis.
Table Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.